• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Report: Why is there still an N95 shortage?

Report: Why is there still an N95 shortage?

September 21, 2020 By Nancy Crotti

Millions of 3M N95 masks arrive at BWI airport in April. (Image courtesy of 3M)

The nationwide shortage of N95 respirators needed by healthcare workers and others during the coronavirus pandemic shows no indications of letting up, according to an article in today’s Washington Post.

The newspaper cites a lack of inter-industry cooperation on N95 production, the Trump administration’s use of the Defense Production Act to force companies to make ventilators but not N95s, and 3M’s efforts to boost production that still may not meet demand as fall and winter approach.

Maplewood, Minn.-based 3M (NYSE:MMM) has invested $100 million to expand domestic production of respirators from 22 million to 50 million per month, according to the Post. The company expects to launch a new production line at its Aberdeen, S.D., plant in October.

The U.S. Department of Defense awarded $133 million in N95 respirator contracts in April to 3M, Owens & Minor (NYSE:OMI) and Honeywell (NYSE:HON).

Since January, 3M has doubled N95 respirator production globally and is on track to produce 2 billion respirators globally by the end of 2020, according to spokesperson Tim Post.

“We continue to increase production in the U.S. We expect to produce 95 million N95 respirators per month by October, nearly three times as many as in April, or a rate of more than 1 billion respirators per year,” Post added in an email to MassDevice. “Even with 3M’s accelerated production combined with capacity from other manufacturers, the demand for N95 and other respirators continues to exceed supply for the entire industry and will for the foreseeable future.”

Honeywell spokesperson Eric Krantz said in an email that the company began N95 production in April at two facilities in just five weeks , a process that could typically take up to nine months.

“By the end of this year, our mask production rate will be 60 times larger than what it was in April,” Krantz added. “For competitive reasons, we do not disclose specific production numbers.”

Owens & Minor said on its website that it has “invested heavily to expand manufacturing capacity” of personal protective equipment, with most PPE manufacturing located within the U.S. and the Americas.

“To date, these efforts have enabled the expansion of manufacturing capacity for N95 masks by 300%, as well as expanded manufacturing capacity for ear loop and surgical masks and for surgical gowns, compared to 2019 levels,” the company said.

This article has been updated with comments from 3M and Honeywell.

 

 

Filed Under: Business/Financial News, Distribution, Featured, Hospital Care, Respiratory Tagged With: 3m, coronavirus, COVID-19, Honeywell, Owens and Minor, U.S. Department of Defense

More recent news

  • Neuralink files to raise $649M in new equity offering
  • BofA: Surgical robot remanufacturing not a major setback for Intuitive
  • InspireMD wins CE Mark approval for CGuard Prime
  • Philips reports first cases for VeriSight Pro 3D ICE catheter in Europe
  • Ceryx Medical raises $15M to support bioelectronic pacemaker

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy